beta

ALNY

Alnylam Pharmaceuticals, Inc.

Alny

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Market Cap: 13.8 Billion

Primary Exchange: NASDAQ

Website: http://www.alnylam.com

Shares Outstanding: 111 Million

Float: 110 Million

Dividend: (%)

Beta: 1.36188998451412

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Animal testing

Longest drawdown: 603 trading days

From: 2015-06-22 To: 2017-11-09

Lowest Point:

Alnylam to Report New Clinical Results for ONPATTRO® (patisiran) at Peripheral Nerve Society (PNS) Annual Meeting and the 5th Congress of the European Academy of Neurology (EAN)

via: Business Wire at 2019-06-13 04:00:00:000

Data from Ongoing Open-Label Extension Study Highlight Durable Halting or Reversal of Neuropathy Disease Progression Relative to Baseline and Consistent Safety Profile of ONPATTRO in Patients with hATTR Amyloidosis Alnylam to Share Data Evaluating Treatment w… read more...

BIIB Is For Buy-O-Gen

via: SeekingAlpha at 2019-06-12 06:30:36:000

Let's spell Biogen Buy-o-Gen. Indeed, BIIB seems increasingly appealing at current price. The biotech focuses on discovering, developing, and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets various products for multiple sc… read more...

Alnylam Pharmaceuticals (ALNY) Investor Presentation - Slideshow

via: SeekingAlpha at 2019-06-10 07:37:51:000

The following slide deck was published by Alnylam Pharmaceuticals, Inc. in conjunction with this Read more … read more...

Alnylam Pharmaceuticals (ALNY) Investor Presentation - Slideshow

via: SeekingAlpha at 2019-06-10 07:37:51:000

The following slide deck was published by Alnylam Pharmaceuticals, Inc. in conjunction with this Read more … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud